Product Information

LABETALOL HCL 100 MG TABLET is a generic product labeled by Innogenix, Inc., priced at $0.0830 per EA under NDC 71247012601. Its NADAC has been published 244 times since Jun 23, 2021.

FDA first approved this application on Jul 29, 1999. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LABETALOL HCL 100 MG TABLET

Labetalol Hydrochloride
$0.0830per EA

Strength

100 mg/1

Manufacturer

Innogenix, Inc.

NDC

71247012601

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

2/18/2026

Active Ingredients

LABETALOL HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075215

FDA Approved

7/29/1999

TE Code

AB

On Market Since

2/8/2021

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for LABETALOL HCL 100 MG TABLET has been published 244 times since Jun 23, 2021, and over the history we have for it it has declined 45.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0830 per EA
All-time high$0.1624 (Nov 10, 2021)
All-time low$0.0811 (Feb 19, 2025)
52-week high$0.0852
52-week low$0.0830
Median price$0.1115
Average price$0.1093
Largest weekly change+34.4% (Jun 19, 2024)
Weeks tracked244
Tracking sinceJun 23, 2021

Price History

1W

N/A

1M

N/A

3M

N/A

6M

N/A

1Y

-2.6%

3Y

-24.6%

5Y

-45.2%

All

-45.1%

Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LABETALOL HCL 100 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LABETALOL HCL 100 MG TABLET, manufactured by Innogenix, Inc., is $0.0830 per EA (NDC 71247012601), effective Feb 18, 2026.

How has the price of LABETALOL HCL 100 MG TABLET changed over time?

Over the history we have for it, the NADAC for LABETALOL HCL 100 MG TABLET has declined 45.1%. It has been tracked across 244 weekly CMS publications since Jun 23, 2021.

What are the highest and lowest recorded NADAC prices for LABETALOL HCL 100 MG TABLET?

Since Jun 23, 2021, the NADAC for LABETALOL HCL 100 MG TABLET has ranged from a low of $0.0811 (Feb 19, 2025) to a high of $0.1624 (Nov 10, 2021), with a median of $0.1115 per EA.

Are there cheaper alternatives to LABETALOL HCL 100 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LABETALOL HCL 100 MG TABLET, is $0.0807 per EA — about 3% below LABETALOL HCL 100 MG TABLET.

Who manufactures LABETALOL HCL 100 MG TABLET?

LABETALOL HCL 100 MG TABLET (NDC 71247012601) is labeled by Innogenix, Inc., and CMS classifies it as a generic product.